ALNY 8-K 2026-01-12

ALNYLAM PHARMACEUTICALS, INC. (ALNY) 8-K dated 2026-01-12 — accession 0001628280-26-001755. This URL is the filing, not the ALNY hub.

ALNYLAM PHARMACEUTICALS, INC. (ALNY) is a biotechnology company listed on US.

ALNYLAM PHARMACEUTICALS, INC. filed a 8-K on 2026-01-12. Accession 0001628280-26-001755.

Cached items: 2.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ALNY revenue for 2025-12-31 was $3.71B. Net income was $313.7M. Revenue was up 65.2% from 2024-12-31 to 2025-12-31. ALNY currently screens at market cap $40.46B and trailing P/E 37.4.

Not investment advice. The ALNY SEC hub lists recent forms. The stock page is the research view.